Literature DB >> 21554781

Costs of illness due to endemic cholera.

C Poulos1, A Riewpaiboon, J F Stewart, J Clemens, S Guh, M Agtini, D Sur, Z Islam, M Lucas, D Whittington.   

Abstract

Economic analyses of cholera immunization programmes require estimates of the costs of cholera. The Diseases of the Most Impoverished programme measured the public, provider, and patient costs of culture-confirmed cholera in four study sites with endemic cholera using a combination of hospital- and community-based studies. Families with culture-proven cases were surveyed at home 7 and 14 days after confirmation of illness. Public costs were measured at local health facilities using a micro-costing methodology. Hospital-based studies found that the costs of severe cholera were US$32 and US$47 in Matlab and Beira. Community-based studies in North Jakarta and Kolkata found that cholera cases cost between US$28 and US$206, depending on hospitalization. Patients' cost of illness as a percentage of average monthly income were 21% and 65% for hospitalized cases in Kolkata and North Jakarta, respectively. This burden on families is not captured by studies that adopt a provider perspective.

Entities:  

Mesh:

Year:  2011        PMID: 21554781      PMCID: PMC3824392          DOI: 10.1017/S0950268811000513

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  19 in total

1.  Household cost of seeking malaria care. A retrospective study of two districts in Ghana.

Authors:  W K Asenso-Okyere; J A Dzator
Journal:  Soc Sci Med       Date:  1997-09       Impact factor: 4.634

2.  A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community.

Authors:  Christine Poulos; Rajiv Bahl; Dale Whittington; Maharaj K Bhan; John D Clemens; Camilo J Acosta
Journal:  J Health Popul Nutr       Date:  2004-09       Impact factor: 2.000

3.  Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia.

Authors:  Denise DeRoeck; John D Clemens; Andrew Nyamete; Richard T Mahoney
Journal:  Vaccine       Date:  2005-04-15       Impact factor: 3.641

4.  The burden of cholera in the slums of Kolkata, India: data from a prospective, community based study.

Authors:  D Sur; J L Deen; B Manna; S K Niyogi; A K Deb; S Kanungo; B L Sarkar; D R Kim; M C Danovaro-Holliday; K Holliday; V K Gupta; M Ali; L von Seidlein; J D Clemens; S K Bhattacharya
Journal:  Arch Dis Child       Date:  2005-06-17       Impact factor: 3.791

5.  A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.

Authors:  S T Cookson; D Stamboulian; J Demonte; L Quero; C Martinez de Arquiza; A Aleman; A Lepetic; M M Levine
Journal:  Int J Epidemiol       Date:  1997-02       Impact factor: 7.196

6.  Effectiveness of mass oral cholera vaccination in Beira, Mozambique.

Authors:  Marcelino E S Lucas; Jacqueline L Deen; Lorenz von Seidlein; Xuan-Yi Wang; Julia Ampuero; Mahesh Puri; Mohammad Ali; M Ansaruzzaman; Juvenaldo Amos; Arminda Macuamule; Philippe Cavailler; Philippe J Guerin; Claude Mahoudeau; Pierre Kahozi-Sangwa; Claire-Lise Chaignat; Avertino Barreto; Francisco F Songane; John D Clemens
Journal:  N Engl J Med       Date:  2005-02-24       Impact factor: 91.245

7.  Costs of diarrhoeal diseases and the savings from a control programme in Cebu, Philippines.

Authors:  B C Forsberg; E Sullesta; S Pieche; N Lambo
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

8.  Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy.

Authors:  Rajiv Bahl; Anju Sinha; Christine Poulos; Dale Whittington; Sunil Sazawal; Ramesh Kumar; Dilip Mahalanabis; Camilo J Acosta; John D Clemens; Maharaj K Bhan
Journal:  J Health Popul Nutr       Date:  2004-09       Impact factor: 2.000

9.  Treatment of diarrhoea in Indonesian children: what it costs and who pays for it.

Authors:  S J Lerman; D S Shepard; R A Cash
Journal:  Lancet       Date:  1985-09-21       Impact factor: 79.321

10.  Private demand for cholera vaccines in Hue, Vietnam.

Authors:  Dohyeong Kim; Do G Canh; Christine Poulos; Le T K Thoa; Joe Cook; Nguyen T Hoa; Andrew Nyamete; Dang T D Thuy; Jacqueline Deen; John Clemens; Vu D Thiem; Dang D Anh; Dale Whittington
Journal:  Value Health       Date:  2008 Jan-Feb       Impact factor: 5.725

View more
  17 in total

Review 1.  Economics and financing of vaccines for diarrheal diseases.

Authors:  Sarah M Bartsch; Bruce Y Lee
Journal:  Hum Vaccin Immunother       Date:  2014-04-22       Impact factor: 3.452

2.  Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.

Authors:  Christian Schaetti; Mitchell G Weiss; Said M Ali; Claire-Lise Chaignat; Ahmed M Khatib; Rita Reyburn; Radboud J Duintjer Tebbens; Raymond Hutubessy
Journal:  PLoS Negl Trop Dis       Date:  2012-10-04

3.  An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India.

Authors:  Vittal Mogasale; Shantanu K Kar; Jong-Hoon Kim; Vijayalaxmi V Mogasale; Anna S Kerketta; Bikash Patnaik; Shyam Bandhu Rath; Mahesh K Puri; Young Ae You; Hemant K Khuntia; Brian Maskery; Thomas F Wierzba; Binod Sah
Journal:  PLoS Negl Trop Dis       Date:  2015-09-09

4.  Economic and environmental impacts of harmful non-indigenous species in southeast Asia.

Authors:  Le T P Nghiem; Tarek Soliman; Darren C J Yeo; Hugh T W Tan; Theodore A Evans; John D Mumford; Reuben P Keller; Richard H A Baker; Richard T Corlett; Luis R Carrasco
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

5.  Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons.

Authors:  Sanjukta Sen Gupta; Kaushik Bharati; Dipika Sur; Ajay Khera; N K Ganguly; G Balakrish Nair
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

6.  Cost of illness for outpatients attending public and private hospitals in Bangladesh.

Authors:  Md Sadik Pavel; Sayan Chakrabarty; Jeff Gow
Journal:  Int J Equity Health       Date:  2016-10-10

7.  Cost of illness for severe and non-severe diarrhea borne by households in a low-income urban community of Bangladesh: A cross-sectional study.

Authors:  Rebeca Sultana; Stephen P Luby; Emily S Gurley; Nadia Ali Rimi; Sayeda Tasnuva Swarna; Jahangir A M Khan; Nazmun Nahar; Probir Kumar Ghosh; Sushil Ranjan Howlader; Humayun Kabir; Shifat Khan; Peter Kjær Mackie Jensen
Journal:  PLoS Negl Trop Dis       Date:  2021-06-11

8.  Knowledge of, attitudes toward, and preventive practices relating to cholera and oral cholera vaccine among urban high-risk groups: findings of a cross-sectional study in Dhaka, Bangladesh.

Authors:  Tasnuva Wahed; Sheikh Shah Tanvir Kaukab; Nirod Chandra Saha; Iqbal Ansary Khan; Farhana Khanam; Fahima Chowdhury; Amit Saha; Ashraful Islam Khan; Ashraf Uddin Siddik; Alejandro Cravioto; Firdausi Qadri; Jasim Uddin
Journal:  BMC Public Health       Date:  2013-03-19       Impact factor: 3.295

9.  Comparing sociocultural features of cholera in three endemic African settings.

Authors:  Christian Schaetti; Neisha Sundaram; Sonja Merten; Said M Ali; Erick O Nyambedha; Bruno Lapika; Claire-Lise Chaignat; Raymond Hutubessy; Mitchell G Weiss
Journal:  BMC Med       Date:  2013-09-18       Impact factor: 8.775

10.  Cost of illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspective.

Authors:  Abdur Razzaque Sarker; Ziaul Islam; Iqbal Ansary Khan; Amit Saha; Fahima Chowdhury; Ashraful Islam Khan; Firdausi Qadri; Jahangir A M Khan
Journal:  BMC Infect Dis       Date:  2013-11-04       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.